ArticleFrontiers in pharmacology2023

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations.

Lijuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.